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Background: There have been previous studies associating microorganisms to cancer and with our recent findings
of Blastocytsis antigen having a higher in vitro proliferation of cancer cells strengthens the suspicion. Collecting
faecal samples alone to associate this parasite with cancer may not be accurate due to the phenomenon of
irregular shedding and the possible treatment administrated to the cancer patients. Hence, this become the basis
to search for an alternate method of sample collection. Colonic washout is an almost complete washed up material
from colon and rectum which includes various microorganisms such as Blastocystis and other lodged material
within the villi. The detection of parasite in colonic washouts will give a better reflection on the association
between Blastocystis and CRC.
Methods: Blastocytsis detection was made by in vitro culture method using Jones’ medium, formal ether
concentration technique and conventional polymerase chain reaction (PCR) on faecal samples and colonic
washouts of 204 CRC patients from colonoscopy procedure. Faecal samples and colonic washouts from 221 normal
individuals served as control.
Results: We observed an increased detection of Blastocystis using colonic washouts (n = 53, 12.47%) than faecal
samples (n = 26, 6.12%). Eleven faecal samples showed positive results for Blastocystis which were also found in
colonic washouts using the PCR technique. This study for the first time showed a significant Blastocystis infection
among CRC patients (n = 43, 21.08%) compared to the asymptomatic normal individuals (n = 22, 9.95%). Blastocystis
subtype 3 infection was found to be significantly more prevalent (n = 26, 12.75%) compared to other subtypes
namely subtype 1: n = 9 (4.41%), subtype 2: n = 1 (0.49%), subtype 5: n = 1 (0.49%) and mixed subtype: n = 6 (2.94%)
among the CRC patients.
Conclusion: The study showed that colonic washouts provide a better alternative for Blastocystis detection in CRC
patients compared to faecal samples as this prevents treatment regime and the phenomenon of irregular shedding
from influencing the detection results obtained from faecal samples.
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Blastocystis is one of the most commonly detected micro-
organisms in the human gut [1]. It is known to cause many
non-specific symptoms such as stomach bloating and diar-
rhea [2]. Among colorectal cancer (CRC) patients, the
prevalence of Blastocystis is yet to be determined probably
due to the lack of evidence to show its pathogenic role.* Correspondence: suresh@um.edu.my
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article, unless otherwise stated.Considering the fact that human intestine is often ex-
posed to various microorganisms, the putative role of
infectious agents in causing gastrointestinal disorders in-
cluding CRC is undeniable. In addition, nearly 18% of all
cancers worldwide were associated with infectious agents
[3]. Human colon can easily allow the growth of over 500
different species of bacteria due to its environment which
is rich in nutrients [4].
Blastocystis infection was also reported to be frequent in
cancer and HIV/AIDS patients with gastrointestinal symp-
toms [5]. Although ten different subtypes of Blastocystis
(Subtype 1 – Subtype 10) have been identified thus farentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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often been hampered by the poor sensitivity of standard
methods available to detect Blastocystis genotypes in fae-
cal samples. While a previous in vitro study have demon-
strated that the solubilized antigen of Blastocystis could
proliferate colon cancer cells [3], the present study at-
tempts to assess the prevalence of Blastocystis in CRC pa-
tients. However, detection of Blastocystis becomes harder
in this cohort as these patients are likely to undergo
chemotherapy and other drug treatments that probably
could have killed the organism. The irregular shedding re-
ported previously [9] raises the possibility that Blastocystis
detection in faecal samples could be missed. Therefore in
the present study we attempted to compare the prevalence
of Blastocystis using colonic washouts and faecal samples
to identify the Blastocystis genotype present. It is highly
probable that a better Blastocystis occurrence in patients
with CRC can be obtained when colonic washouts are
used as sample material. Patients resort to colonoscopy
only as a last resort to finding the cause when the initial
screening and treatment do not relieve symptoms. The
possibility of re-covering parasites from colonic washout
is higher as it contains an almost complete washed up ma-
terial from colon and rectum which includes various




This is a hospitalized-based cross-sectional study of 425
patients who underwent diagnostic colonoscopy in Univer-
sity of Malaya Medical Centre (UMMC). The samples were
collected over a 2-year period, between 2010 and 2012.
Colonoscopy is usually recommended for screening and
prevention of colorectal cancer (CRC). Over 751 potential
participants were briefed about this study but only 425 pa-
tients were interested. They were provided with a consent
form in person. They belonged to two cohorts- a group of
221 patients who came for normal screening and 204 pa-
tients presenting colorectal malignancies. This study was
approved by the Medical Ethics Committee of the UMMC
in accordance with the declaration of Helsinki.
Specimen collection and screening
Colonic washouts were obtained at the time of (or imme-
diately prior to) the diagnosis of CRC. Whereas, faecal
samples were obtained via the standard clinical procedures
whereby patients will be given a duration of 1–2 weeks to
deliver their faecal samples. Colonic washouts were col-
lected in clean disposable bowls. Each sample was centri-
fuged at 1,400 × g and the pellets obtained were cultured
in Jones’ medium [10] supplemented with 10% horse
serum [11] and incubated at 37°C for 24 h and then
screened for Blastocystis. DNA was extracted from theremaining fresh colonic washout for genotyping purposes.
A pea size of the faecal samples collected from the same in-
dividuals were directly cultured in Jones’ medium and other
procedures carried out were similar to that of colonic wash-
out. Predominant Blastocystis subtype was identified using
polymerase chain reaction (PCR) technique.
Formal ether concentration technique
Fresh colonic washout and faecal samples were routinely
processed by the formal ether concentration technique
(FECT) to obtain stool concentrate. Ficoll-Paque density
gradient centrifugation method was carried out to isolate
Blastocystis cyst from the concentrate [11]. Briefly, the
stool concentrate re-suspended in PBS was layered on
5 ml of Ficoll-Paque and centrifuged at 1,600 × g for
20 minutes. Blastocystis cyst layer which was formed
after centrifugation was removed into another Falcon
tube and re-suspended in 1 ml PBS and observed under
microscope for the detection of Blastocystis cyst.
DNA extraction and genotyping
PCR technique was used to detect Blastocystis in addition
to standard stool culture technique in both colonic wash-
outs and faecal samples. DNA extraction was conducted
usingQIAamp® DNA Stool Mini Kit (QIAGEN). Briefly,
200 ml of the sediments of colonic washout samples or
faecal samples were used to extract DNA. PCR was carried
out with specific sequence-tagged site (STS) primers
(Table 1). Seven different STS primers were used for geno-
typing as described previously [6,7,12-18]. The STS
primers used were SB83 (351 bp), SB340 (704 bp), SB227
(526 bp), SB337 (487 bp), SB336 (317 bp), SB332 (338 bp)
and SB 155 (650 bp) for subtype 1, 2, 3, 4, 5, 6 and 7 re-
spectively based on a recent classification terminology
[19]. One microliter of DNA preparation was used to
amplify the genomic sequences in a 20 μl PCR cocktail
containing 0.2 mM of the four dNTPs, 25 pmol of each
primer, 1× PCR buffer (75 mMTris–HCl, pH 8.8, 20 mM
(NH4)2SO4, and 0.01% Tween 20), 2.5 mM MgCl, and 1 U
Taq DNA polymerase (recombinant) (Fermentas). PCR
was carried out with one cycle denaturing at 95°C for
5 min, 42 cycles including annealing at 56.3°C for 90 s, ex-
tending at for 60 s, and additional cycle with a 10 min
chain elongation at 72°C (Thermal cycler, BIO-RAD, USA).
The PCR products and a size marker of a 100-bp ladder
were electrophoresed in 1.5% agarose gels (Promega, USA)
which were stained with ethidium bromide and photo-
graphed using an ultraviolet gel documentation system
(Uvitec, UK). PCR amplification for each primer pair was
repeated thrice for each positive sample.
Statistical analysis
Data were analyzed using Statistical Package for Social
Sciences for Windows SPSS (Version 17.0). The Chi





Sequences of forward (F) and





Clade in the SSU
rRNA phylogenya
1 SB83 351 F GAAGGACTCTCTGACGATGA Nand II AF166086 Yoshikawa et al. [6] I
R GTCCAAATGAAAGGCAGC
2 SB155 650 F ATCAGCCTACAATCTCCTC B AF166087 VII
R ATCGCCACTTCTCCAAT
3 SB227 526 F TAGGATTTGGTGTTTGGAGA R HV93–13 AF166088 Yoshikawa et al. [7] III
TTAGAAGTGAAGGAGATGGAAG
4 SB332 338 F GCATCCAGACTACTATCAACATT HJ96AS-1 AF166091 VI
R CCATTTTCAGACAACCACTTA
5 SB340 704 F TGTTCTTGTGTCTTCTCAGCTC HJ96–1 AY048752 Yoshikawa et al. [18] II
R TTCTTTCACACTCCCGTCAT
6 SB336 317 F GTGGGTAGAGGAAGGAAAACA SY94–3 AY048751 V
R AGAACAAGTCGATGAAGTGAGAT
7 SB337 487 F GTCTTTCCCTGTCTATTCTGCA RN94–9 AY048750 IV
R AATTCGGTCTGCTTCTTCTG
Kumarasamy et al. Parasites & Vectors 2014, 7:162 Page 3 of 5
http://www.parasitesandvectors.com/content/7/1/162squared test was used to determine significance of differ-
ences in prevalence of Blastocystis between the healthy
individuals and CRC patients. Fisher’s Exact test was
used to determine the pre-dominant Blastocystis subtype
in the colonic washouts of normal and CRC patients. In
all the analyses, a probability level of p < 0.05 was used
to indicate statistical significance.
Results
Blastocystis detection in the faecal samples and colonic
washouts
The overall prevalence of Blastocystis infection obtained
from the three methods used was 15.29% (65/425). There
were 65/425, 4/425, and 4/425 samples (including faecal
samples and colonic washouts) detected positive for Blasto-
cystis via PCR, in vitro cultivation and formal ether concen-
tration technique respectively. Overlapping positive results
were often observed in faecal samples and colonic washouts
as well as among the different techniques used. Colonic
washouts and faecal samples showed 12.24% (n = 52) and
5.65% (n = 24) of Blastocystis infection respectively via the
conventional PCR technique. Forty-one colonic washouts
were positive for Blastocystis, despite the faecal samples
from the same patients being negative for Blastocystis.
Whereas, 11 faecal samples identified positive for Blastocys-
tis also showed positive for colonic washouts obtained from
the same patients using PCR technique. A very small per-
centage (0.96%, n = 4) of faecal samples were found positive
via in vitro cultivation of faecal samples but none from co-
lonic washouts. Although other parasites such as Ascaris
lumbricoides and hook worm were detected via formal
ether concentration technique but the frequency was negli-
gible and statistically non-significant.Blastocystis infection and subtype analysis in CRC patients
A total of 43 (21.08%) samples were positive for Blastocys-
tis infection in CRC patients and was significantly higher
compared to normal individuals (n = 22, 9.95%, p < 0.01)
(Figure 1). We conducted conventional PCR [20] to classify
Blastocystis into certain subtype. In the current study, four
different Blastocystis genotypes were identified among all
the subjects namely subtype 1 (ST1), subtype 2 (ST2), sub-
type 3 (ST3), subtype 5 (ST5) and mixed subtypes. Subtype
6 (ST6) and subtype 7 (ST7) were not detected in all cases.
ST3 was present at higher levels compared to other sub-
types detected in both groups as shown in Table 2. Overall,
ST3 was the most prevalent subtype (n = 30, 14.71%),
whereas ST1, ST2, and ST5 were seen in 5.39% (n = 11),
3.43% (n = 7) and 0.49% (n = 1) of the CRC patients, re-
spectively. Besides that, mixed subtype infections were
detected in six samples which were 0.98% (n = 2, ST1
and ST2) and 1.96% (n = 4, ST2 and ST3) (Table 2). ST3
infection was also found to be statistically significant in
CRC patients as compared with the control group
(Table 2).
Discussion
Faecal sample collection of more than three times from
the same person have been shown to significantly raise the
possibility of detecting parasites [9]. However this would
be too tedious and troublesome to execute. The faecal
sample collection was purposely carried out as how it
would be for routine screening purpose after the CRC
diagnosis regardless of pre or post-treatment regime
which could not be avoided. Therefore, the chances of re-
covering parasites which could have been influenced by
the treatment regime cannot be overruled. The irregular




n=43, 21.08 %  **
n=22,  9.95 %





Colonic washouts + Faecal samples
Faecal samples
Colonic washouts
Figure 1 Percentage of Blastocystis infection in colonic washouts and faecal samples collected from CRC and normal individuals.
**p < 0.01 is the comparison done between CRC patients and normal individuals.
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pound the challenge for detecting these parasites des-
pite the use of the standard faecal culture technique [9].
In addition, detection using microscope is a greater
challenge when parasites present in very small numbers
in the faecal samples. As such, the usage of colonic
washout probably far more effective as it can be col-
lected almost immediately during diagnosis and the de-
tection without the influence of any previous treatment
regime. The diagnostic method to determine the pres-
ence of Blastocystis vary widely in sensitivity. Possibility
of Blastocystis being eliminated by treatment usually
sought by CRC patients for their initial symptoms could
have resulted in zero detection in the present study using
both formal-ether concentration technique and the gold
standard in vitro cultivation method. Therefore, PCR tech-
nique was employed for the screening of Blastocystis in
both faecal samples and colonic washouts. Blastocystis was
detected in colonic washout samples from patients who
were tested negative for Blastocystis by using faecal sample.
This is the first study that detects Blastocystis in colonic





(n = 204)% (No. positive)
Healthy individuals
(n = 221)% (No. positive)
Subtype 1 4.41 (9)* 2.71 (6)
Subtype 2 0.49 (1)** 0.90 (2)*
Subtype 3 12.75 (26)# 3.17 (7)
Subtype 1 + 2 0.98 (2)** 0 (0)
Subtype 2 + 3 1.96 (4)* 1.81 (4)
Subtype 5 0.49 (1)** 1.36 (3)
*p < 0.05; **p < 0.01 are levels of significance between subtype 3 Blastocystis
and other subtypes.
#p < 0.05 is the significant difference in Blastocystis (subtype) infection
between CRC patients and healthy individuals.PCR method. These samples were collected at the initial
stage of cancer detection which excluded the possibility of
the patients undergoing medical treatments such as chemo-
therapy which could have killed the parasites. Although
pathogenicity of Blastocystis is controversial, Blastocystis
screening in CRC patients is crucial considering the recent
in vitro studies providing evidences of the parasite’s exacer-
bating potential in proliferating cancer cells [21-23]. This
method probably can be one of the more effective ways to
screen for Blastocystis for high risk individuals and
those who are suspected of infection but found negative
by other less sensitive methods. The collection of co-
lonic washouts is easier as it is a waste product pro-
duced from colonoscopy procedure. Furthermore, the
chances for cross-contamination can be prevented as it
can be collected directly and almost immediately from
patients who are undergoing colonoscopy. This method
may preferably be used for individuals that go through
colonoscopy procedure for other diagnosis purposes
such as CRC and those who are suspected of infection
but found to be negative by other available methods.
Predominance of Blastocystis ST3 was similar to a
previous study conducted among patients in a hospital
in Singapore [24]. Blastocystis ST3 was reported to be
the only subtype of human origin, while the rest being
zoonotic [25]. As an earlier report suggested a possible
correlation between ST3 and pathogenic potential [26],
it is crucial for subtype identification. This will enable
us to understand better, the possible pathogenic role of
these subtypes play to the worsening of cancer. Further-
more, the occurrence of other cases such as acute urti-
caria and gastrointestinal symptoms were reported in
patients with ST3 infection [27]. We observed a very
low prevalence of ST1 and ST2 in both CRC and
healthy individuals. These subtypes were mainly associ-
ated with zoonotic transmission. Similarly, ST4, ST6
and ST7 were not found in these patient groups as they
are mostly zoonotic microorganisms [28].
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In conclusion, this study demonstrated that colonic wash-
outs can be a better alternative to fecal samples to exam-
ine for Blastocystis infection especially in CRC cases. Our
study shows that Blastocystis infection is common in CRC
patients and it indicates subtype 3 as predominant among
these individuals. However, the pathogenic role of this
parasite in CRC patients is still unclear. Therefore, further
study has to be conducted to determine the correlation
between the genotype and symptomatology.
Competing interests
The authors declare that they have no competing interest.
Authors’ contributions
VK, SKG, ACR and URK participated in the design of the study. VK did the data and
sample collections from the patients. VK, SKG, ACR and URK did the data analysis.
VK wrote the manuscript. All authors read and approved the final manuscript.
Acknowledgments
We are grateful to personnel at University of Malaya Medical Centre for
continues support and in assisting us sample collection, and to the
Department of Parasitology of University of Malaya for providing facilities for
us to conduct the research. Funding for this study was provided by High
Impact Research Grant UM.C/625/1/HIR 031 and University of Malaya
Postgraduate Research Grant (PPP) – Research PG108-2012B.
Author details
1Department of Parasitology, Faculty of Medicine, University of Malaya, Kuala
Lumpur 50603, Malaysia. 2Department of Surgery, Faculty of Medicine,
University of Malaya, Kuala Lumpur 50603, Malaysia. 3Department of
Biomedical Science, Faculty of Medicine, University of Malaya, Kuala Lumpur
50603, Malaysia.
Received: 17 January 2014 Accepted: 12 March 2014
Published: 3 April 2014
References
1. Zierdt C, Rude W, Bull B: Protozoan characteristics of Blastocystis hominis.
Am J Clin Pathol 1967, 48:495.
2. Suresh K, Venilla G, Tan T, Rohela M: In vivo encystation of Blastocystis
hominis. Parasitol Res 2009, 104:1373–1380.
3. Parkin DM: The global health burden of infection‐associated cancers in
the year 2002. Int J Cancer 2006, 118:3030–3044.
4. Guarner F: Enteric flora in health and disease. Digestion 2006, 73:5–12.
5. Tan T, Ong S, Suresh K: Genetic variability of Blastocystis sp. isolates
obtained from cancer and HIV/AIDS patients. Parasitol Res 2009,
105:1283–1286.
6. Yoshikawa H, Nagano I, Wu Z, Yap EH, Singh M, Takahashi Y: Genomic
polymorphism among Blastocystis hominis strains and development of
subtype-specific diagnostic primers. Mol Cell Probes 1998, 12:153–159.
7. Yoshikawa H, Abe N, Iwasawa M, Kitano S, Nagano I, Wu Z, Takahashi Y:
Genomic analysis of Blastocystis hominisStrains isolated from two
long-term health care facilities. J Clin Microbiol 2000, 38:1324–1330.
8. Yoshikawa H, Abe N, Wu Z: PCR-based identification of zoonotic isolates of
Blastocystis from mammals and birds. Microbiology 2004, 150:1147–1151.
9. Vennila G, Suresh Kumar G, Khairul Anuar A, Rajah S, Saminathan R,
Sivanandan S, Ramakrishnan K: Irregular shedding of Blastocystis hominis.
Parasitol Res 1999, 85:162–164.
10. Jones W: The experimental infection of rats with Entamoeba histolytica;
with a method for evaluating the anti-amoebic properties of new
compounds. Ann Trop Med Parasitol 1946, 40:130.
11. Suresh K, Smith H: Comparison of methods for detecting Blastocystis
hominis. Eur J Clin Microbiol Infect Dis 2004, 23:509–511.
12. Abe N, Wu Z, Yoshikawa H: Molecular characterization of Blastocystis
isolates from birds by PCR with diagnostic primers and restriction
fragment length polymorphism analysis of the small subunit ribosomal
RNA gene. Parasitol Res 2003, 89:393–396.13. Abe N, Wu Z, Yoshikawa H: Molecular characterization of Blastocystis
isolates from primates. Vet Parasitol 2003, 113:321–325.
14. Abe N, Wu Z, Yoshikawa H: Zoonotic genotypes of Blastocystis hominis
detected in cattle and pigs by PCR with diagnostic primers and
restriction fragment length polymorphism analysis of the small subunit
ribosomal RNA gene. Parasitol Res 2003, 90:124–128.
15. Li LH, Zhang XP, Lv S, Zhang L, Yoshikawa H, Wu Z, Steinmann P, Utzinger J,
Tong XM, Chen SH: Cross-sectional surveys and subtype classification of
human Blastocystis isolates from four epidemiological settings in China.
Parasitol Res 2007, 102:83–90.
16. Li L-H, Zhou X-N, Du Z-W, Wang X-Z, Wang L-B, Jiang J-Y, Yoshikawa H,
Steinmann P, Utzinger J, Wu Z: Molecular epidemiology of human Blastocys-
tis in a village in Yunnan province, China. Parasitol Int 2007, 56:281–286.
17. Yan Y, Su S, Lai R, Liao H, Ye J, Li X, Luo X, Chen G: Genetic variability of
Blastocystis hominis isolates in China. Parasitol Res 2006, 99:597–601.
18. Yoshikawa H, Abe N, WU Z: Genomic polymorphism among Blastocystis
isolates and development of PCR-based identification of zoonotic
isolates. J Eukaryot Microbiol 2003, 50:710–711.
19. Stensvold CR, Suresh GK, Tan KS, Thompson R, Traub RJ, Viscogliosi E,
Yoshikawa H, Clark CG: Terminology for Blastocystis subtypes–a
consensus. Trends Parasitol 2007, 23:93–96.
20. Stensvold C, Traub R, von Samson-Himmelstjerna G, Jespersgaard C, Nielsen H,
Thompson R: Blastocystis: Subtyping isolates using pyrosequencing™
technology. Exp Parasitol 2007, 116:111–119.
21. Chandramathi S, Suresh K, Kuppusamy UR: Solubilized antigen of
Blastocystis hominis facilitates the growth of human colorectal cancer
cells, HCT116. Parasitol Res 2010, 106:941–945.
22. Chan KH, Chandramathi S, Suresh K, Chua KH, Kuppusamy UR: Effects of
symptomatic and asymptomatic isolates of Blastocystis hominis on
colorectal cancer cell line, HCT116. Parasitol Res 2012, 110:2475–2480.
23. Kumarasamy V, Kuppusamy UR, Samudi C, Kumar S: Blastocystis sp. subtype
3 triggers higher proliferation of human colorectal cancer cells, HCT116.
Parasitol Res 2013, 110:3551–3555.
24. Wong KHS, Ng G, Lin RTP, Yoshikawa H, Taylor MB, Tan KSW: Predominance
of subtype 3 among Blastocystis isolates from a major hospital in
Singapore. Parasitol Res 2008, 102:663–670.
25. Noël C, Dufernez F, Gerbod D, Edgcomb VP, Delgado-Viscogliosi P, Ho LC,
Singh M, Wintjens R, Sogin ML, Capron M: Molecular phylogenies of
Blastocystis isolates from different hosts: implications for genetic diversity,
identification of species, and zoonosis. J Clin Microbiol 2005, 43:348–355.
26. Tan T, Suresh K, Smith H: Phenotypic and genotypic characterisation of
Blastocystis hominis isolates implicates subtype 3 as a subtype with
pathogenic potential. Parasitol Res 2008, 104:85–93.
27. Katsarou-Katsari A, Vassalos CM, Tzanetou K, Spanakos G, Papadopoulou C,
Vakalis N: Acute urticaria associated with amoeboid forms of Blastocystis
sp. subtype 3. Acta Dermatovenereol Stockholm 2008, 88:80.
28. Boorom KF, Smith H, Nimri L, Viscogliosi E, Spanakos G, Parkar U, Li LH, Zhou XN,
Ok U, Leelayoova S: Oh my aching gut: irritable bowel syndrome, Blastocystis,
and asymptomatic infection. Parasit Vectors 2008, 1:40.
doi:10.1186/1756-3305-7-162
Cite this article as: Kumarasamy et al.: Advantage of using colonic
washouts for Blastocystis detection in colorectal cancer patients. Parasites &
Vectors 2014 7:162.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
